Lindsey Roeker

20PUBLICATIONS

156CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Oncology and carcinogenesis not elsewhere classifiedMedical molecular engineering of nucleic acids and proteinsMolecular targetsHaematological tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (20)

Sort by Publication Date:

|Jun 30, 2026

Zanubrutinib, Obinutuzumab, and Venetoclax in CLL: Long-Term Follow Up, MRD Kinetics, Retreatment, T-Cell Profiling, PKs.

|Feb 26, 2026

Fitness beyond age: Multidisciplinary expert opinion on redefining fitness for targeted therapies in chronic lymphocytic leukemia.

Raúl Córdoba, Stephan Stilgenbauer, Paolo Ghia

|Oct 07, 2025

Genomic determinants of response and resistance to pirtobrutinib in relapsed/refractory chronic lymphocytic leukemia.

Jennifer R Brown, Bastien Nguyen, Sai Prasad Desikan

|Feb 20, 2025

Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL.

Adam S Kittai, Ying Huang, Sarah Miller

|Oct 14, 2024

HMA/VEN treatment modifications and associated outcomes in <i>IDH</i>-mutant AML.

Kuo-Kai Chin, Andriy Derkach, Christopher Famulare

|Sep 05, 2024

A fresh look at covalent BTK inhibitor resistance.

Lindsey E Roeker

Pageof 4

Frequent Collaborators

Andrew Zelenetz

Meghan C Thompson

Jennifer A Woyach

Mark B Geyer

Toby A Eyre

John N Allan

David A Knorr

Mazyar Shadman

Jeffrey Pu

Paul M Barr

Frequent Collaborators

Andrew Zelenetz

Meghan C Thompson

Jennifer A Woyach

Mark B Geyer